BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
This report contains market size and forecasts of BCG Vaccine in global, including the following market information:
Global BCG Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global BCG Vaccine Market Sales, 2017-2022, 2023-2028, (MT)
Global top five BCG Vaccine companies in 2021 (%)
The global BCG Vaccine market was valued at 384.5 million in 2021 and is projected to reach US$ 554.1 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune BCG Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of BCG Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the BCG Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global BCG Vaccine Market Segment Percentages, by Type, 2021 (%)
Immune BCG
Therapy BCG
Global BCG Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global BCG Vaccine Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global BCG Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global BCG Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies BCG Vaccine revenues share in global market, 2021 (%)
Key companies BCG Vaccine sales in global market, 2017-2022 (Estimated), (MT)
Key companies BCG Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL

LEAVE A REPLY

Please enter your comment!
Please enter your name here